| Dr Nora E O'farrill Herrera, OD | |
|
Road 185 Km 5.0 Bo. Campo Rico, Canovanas, PR 00729 | |
| (787) 886-8066 | |
| (787) 886-8066 |
| Full Name | Dr Nora E O'farrill Herrera |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | Road 185 Km 5.0 Bo. Campo Rico, Canovanas, Puerto Rico |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972779577 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 299 (Puerto Rico) | Primary |
| Provider Name | Pro Vista Inc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1063861235 PECOS PAC ID: 3274820451 Enrollment ID: O20161003002076 |
News Archive
Scientists at the University of Salzburg and Pantec Biosolutions AG have developed a laser-facilitated epicutaneous immunization against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein. The model has induced angiotensin-converting enzyme 2 (ACE2) blocking antibodies in mice.
GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (Nasdaq:XNPT) today announced top-line results from a Phase IIb clinical trial evaluating the safety and efficacy of GSK1838262/XP13512 (gabapentin enacarbil) for neuropathic pain associated with post-herpetic neuralgia (PHN) in adults.
CIGNA and ProHealth Physicians, Inc., have expanded their longstanding relationship by implementing an enhanced care coordination program that includes pay-for-performance provisions and many of the features of a patient-centered medical home program. This is the first program of its kind in Connecticut.
A team of scientists from Sanford Burnham Medical Research Institute has found that the loss of a protein called p62 in the cells and tissue surrounding a tumor can enhance the growth and progression of tumors.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that patients are being enrolled in a Phase 1 clinical trial evaluating IPI-493 in patients with advanced hematologic malignancies. This multi-center study is the second clinical trial of IPI-493, Infinity's oral heat shock protein 90 (Hsp90) chaperone inhibitor.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nora E O'farrill Herrera, OD Po Box 2546, Rio Grande, PR 00745-2546 Ph: (787) 379-8861 | Dr Nora E O'farrill Herrera, OD Road 185 Km 5.0 Bo. Campo Rico, Canovanas, PR 00729 Ph: (787) 886-8066 |
News Archive
Scientists at the University of Salzburg and Pantec Biosolutions AG have developed a laser-facilitated epicutaneous immunization against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein. The model has induced angiotensin-converting enzyme 2 (ACE2) blocking antibodies in mice.
GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (Nasdaq:XNPT) today announced top-line results from a Phase IIb clinical trial evaluating the safety and efficacy of GSK1838262/XP13512 (gabapentin enacarbil) for neuropathic pain associated with post-herpetic neuralgia (PHN) in adults.
CIGNA and ProHealth Physicians, Inc., have expanded their longstanding relationship by implementing an enhanced care coordination program that includes pay-for-performance provisions and many of the features of a patient-centered medical home program. This is the first program of its kind in Connecticut.
A team of scientists from Sanford Burnham Medical Research Institute has found that the loss of a protein called p62 in the cells and tissue surrounding a tumor can enhance the growth and progression of tumors.
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that patients are being enrolled in a Phase 1 clinical trial evaluating IPI-493 in patients with advanced hematologic malignancies. This multi-center study is the second clinical trial of IPI-493, Infinity's oral heat shock protein 90 (Hsp90) chaperone inhibitor.
› Verified 9 days ago
Pro Vista Inc. Optometrist Medicare: Medicare Enrolled Practice Location: Calle 185 Km 5.0, Campo Rico, Canovanas, PR 00729 Phone: 787-886-8066 | |
Best Vision Canovanas Optometrist Medicare: Not Enrolled in Medicare Practice Location: Carretera # 3 Km 19.9, Edificio East Medical Professional Center, Canovanas, PR 00729 Phone: 787-256-6060 Fax: 787-256-6061 | |
Barreto Eye Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 71 Calle Blanco Sosa, Canovanas, PR 00729 Phone: 787-900-3316 | |
Vanessa Marie Cordova, OD Optometrist Medicare: Medicare Enrolled Practice Location: Carr 3 Km 19.9 East Medical Professional Center, Canovanas, PR 00738 Phone: 787-256-6060 | |
Canovanas Eye Group Optometrist Medicare: Not Enrolled in Medicare Practice Location: 5802 Wmsc Plaza Conovanas, Canovanas, PR 00729 Phone: 787-957-2711 Fax: 787-523-0014 | |
Pauling Firm Inc Optometrist Medicare: Medicare Enrolled Practice Location: Carr 3 Km 19.9, Edif East Medical Professional Center, Canovanas, PR 00729 Phone: 787-256-6060 | |
Jtr Optical Center Optometrist Medicare: Medicare Enrolled Practice Location: Rd #3 Km 20.5 Plaza Noreste, Jtr Optical Center, Canovanas, PR 00729 Phone: 787-256-6110 Fax: 787-256-6110 |